The Psychedelic Business Forum: October 15th, 2026, New York

Learn More

From Approvals to Appointments

Join us in New York.

Meet with executives, providers, and regulators at a pivotal moment for psychedelic therapeutics. We have teamed up with Horizons to convene decision-makers to explore the future of psychedelic therapeutics in the United States and beyond.

Join us at the New York Academy of Medicine on October 15th, 2026 to be part of the conversation.

Agenda Preview

Policy

Hear from and engage with federal agencies on issues including regulation, funding, and reimbursement.

Capital

VCs, investment bankers, and other funders share their perspectives on the psychedelics field.

Reimbursement

Private and public payor experts weigh in on a critical component of psychedelic roll-out.

Care Delivery

Explore challenges and opportunities associated with the clinical delivery of psychedelic-based treatments.

Selected Speakers

Josh Hardman

Founder and Editor
Psychedelic Alpha

Matt Zorn

Deputy General Counsel
U.S. Department of Health and Human Services

Lori Englebert

Chief Commercial Officer
Compass Pathways

Connor Williams

Senior Analyst
RTW Investments

AJ Cannon

Executive Medical Director
AbbVie

Myriam Barthes

CEO
Journey Clinical

Andrew Gradison

Senior Advisor
U.S. Department of Veterans Affairs

Edny Inui

Partner
Palo Santo

Jazz Glastra

Senior Director
BrainFutures

Your Hosts

Psychedelic Alpha x Horizons

Psychedelic Alpha has partnered with Horizons: Perspectives on Psychedelics, which is hosting its 19th conference this year, to convene the Psychedelic Business Forum on Thursday 15th October.

Business Forum attendees may also enjoy two further days of programming at the same location, on Friday and Saturday, focused on ‘Science, Medicine, and Psychedelics’ and ‘Psychedelics in the World’, respectively.